# Propranolol Adjuvant Treatment of Focal Refractory Epilepsy (PATFRE)

> **NCT06719804** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 15 (estimated)

## Conditions studied

- Epilepsy, Drug Resistant

## Interventions

- **DRUG:** Propranolol

## Key facts

- **NCT ID:** NCT06719804
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-05
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06719804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06719804, "Propranolol Adjuvant Treatment of Focal Refractory Epilepsy (PATFRE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06719804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*